Shaka Hislop says it is "alarming" that tests for prostate cancer are not "regular and "standardised" in the United Kingdom.

A new three-phase screening protocol that incorporates a PSA test, a four-kallikrein panel, and an MRI scan appears to improve the prostate cancer detection rate among men invited to participate in a ...

Prostate cancer is the most common cancer in men. As a cause of men's cancer death, it ranks the second in Finland and the third in Europe. A large randomized trial conducted at Tampere University and ...

Johnson & Johnson today announced new real world head-to-head evidence demonstrating that patients with metastatic castration ...

Protocol-directed prostate cancer active surveillance offers acceptable oncologic safety. Protocol-directed active surveillance of localized prostate cancer reduces unnecessary treatment of men ...

Radiation therapy is often described in clinical terms, but rarely through the eyes of the person lying on the treatment ...

Confirmatory or systematic prostate biopsies may be unnecessary for men considering active surveillance for prostate cancer who have negative findings on multiparametric MRI scans. Multiparametric MRI ...

About The Study: In this study, 10 years after diagnosis, 49% of men remained free of progression or treatment, less than 2% developed metastatic disease, and less than 1% died of their disease. Later ...

Using PROTECT trial data, investigators assessed the possible benefit of early treatment vs active monitoring for cribriform-positive prostate cancer.

A large randomized trial shows that a new three-step prostate cancer screening method can find a considerable number of aggressive cancers. Population-level screening programs have not been launched ...